AI Summary Cholangiocarcinoma (CCA) is a cancer that starts in the bile ducts, inside or outside the liver. Symptoms include abdominal pain, weight loss, jaundice, and itchy skin. Primary sclerosing cholangitis (PSC) is the strongest risk factor. Doctors diagnose CCA with blood tests, imaging, and tissue sampling. Surgery that removes the whole tumor is the only cure; drug therapy and bile duct drainage help when it cannot be removed. People with PSC should have yearly imaging.
Source: www.liverdirectory.com
Medically reviewed
Cholangiocarcinoma (CCA), also called bile duct cancer, starts in the bile ducts — the tubes that carry bile from the liver to the gallbladder and small intestine. Along with hepatocellular carcinoma, it is one of the two most common types of primary liver cancer.
CCA can start in bile ducts inside or outside the liver. People with long-term bile duct disease, especially primary sclerosing cholangitis, have a higher risk. The only curative treatment is surgery that removes the whole tumor, so finding CCA while it can still be removed matters.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
About CCA
Cholangiocarcinoma (CCA) is cancer that starts in the bile ducts. Bile is a digestive liquid made in the liver. It travels through the bile ducts to the gallbladder and small intestine, where it helps digest fats.
CCA is a primary liver cancer, which means it begins in the bile ducts rather than spreading there from another organ. Hepatocellular carcinoma (HCC) is the other common type. The difference is where the cancer starts: HCC starts in liver cells, and CCA starts in the bile ducts.
In people with chronic liver disease, liver cancer can take years or even decades to develop. Once it is found, it can grow quickly.
Doctors describe CCA by where it starts in the bile duct system.
How CCA may feel
Symptoms of cholangiocarcinoma often come from a blocked bile duct, which keeps bile from draining. They can overlap with other liver and bile duct conditions, so only a doctor can tell them apart.
Getting checked
Doctors diagnose cholangiocarcinoma through a combination of blood tests, imaging, and tissue sampling. Imaging also shows how far the cancer has spread, which guides treatment.
No single test confirms cholangiocarcinoma. Doctors combine symptoms, blood tests, imaging, and tissue sampling, and some cases need review by a team of surgeons and cancer specialists.
Care & treatment
Treatment for cholangiocarcinoma depends on where the tumor is, whether it can be removed, how well the rest of the liver works, and the person's overall health. Plans are individualized and usually involve a team of specialists.
The only curative treatment for intrahepatic cholangiocarcinoma is surgery that removes the whole tumor with clear edges. The part of the liver left behind must be large enough to work safely. After surgery, a 6-month course of the oral medicine capecitabine is recommended. In selected people with PSC and early cholangiocarcinoma, liver transplant may be considered.
When a tumor cannot be removed, doctors may use treatments that target the tumor directly. They may also place stents to keep a blocked bile duct open. Routine stenting before surgery is not advised for people whose tumor can be removed, but it may help some people, such as those with bile duct infection or severe itching.
For cancer that cannot be removed, the first-line treatment for people who are well enough is gemcitabine plus cisplatin. Adding the immunotherapy durvalumab is now the standard of care where it is available. If the cancer grows, doctors may choose a treatment based on the tumor's genetic changes, such as IDH1 mutations, FGFR2 fusions, or MSI-H/dMMR tumors.
There is no single treatment for cholangiocarcinoma that fits everyone. Treatment choice depends on tumor location and whether it can be removed, which is why specialist evaluation and, sometimes, a second opinion are important.
How CCA develops
The cause of most cholangiocarcinomas is not fully understood. Long-term inflammation and injury of the bile ducts and liver create conditions in which cancer can form.
PSC is the strongest known risk factor, and people with cirrhosis or long-term bile duct disease carry a higher risk. Treating viral hepatitis, limiting alcohol, and managing weight and diabetes support liver health.
When to get checked
Early cholangiocarcinoma can cause few symptoms, and symptoms often appear once a bile duct is blocked. Knowing when to get checked, and who needs regular monitoring, can make an important difference.
People with primary sclerosing cholangitis (PSC) have a much higher risk of cholangiocarcinoma. For them, yearly imaging without needles or incisions is suggested, and MRI with MRCP is the suggested option because it is the most accurate for detecting CCA in this group.
Talk with a healthcare provider if you have PSC or another long-term bile duct or liver condition, even if you feel well. Seek prompt evaluation if you notice yellowing of the skin or eyes, dark urine, light-colored stool, severe itching, abdominal pain, or unexplained weight loss.
Surgery that removes the whole tumor is the only curative treatment. Finding cholangiocarcinoma while it can still be removed gives the most treatment options.
A hepatologist or gastroenterologist experienced in bile duct and liver cancer can coordinate testing and treatment with oncology and surgical specialists. Review by a multidisciplinary team is often part of the plan.
Eating & liver health
Diet cannot treat cholangiocarcinoma on its own. Good nutrition supports your liver and your strength during treatment, and it helps manage any underlying liver or bile duct condition.
A liver-friendly eating pattern emphasizes fruits, vegetables, whole grains, and unsaturated fats. It limits added sugar, salt, and trans fats. Drinking enough water throughout the day also helps your body work properly.
If appetite is poor or you are losing weight, your care team may suggest small, frequent meals and work with a registered dietitian. Needs vary with the stage of disease, treatment plan, and overall health, so build your eating plan with your care team.
Explore Liver DietCommon questions
It is a cancer that starts in the bile ducts. It is also called bile duct cancer. Bile ducts are small tubes that carry bile from your liver to your gallbladder and small intestine. Bile is a liquid that helps your body digest fat. CCA is a type of primary liver cancer. The other common type, hepatocellular carcinoma (HCC), starts in liver cells instead. Doctors name CCA by where it starts: inside the liver, where the main liver ducts join, or in the common bile duct.
For most people, doctors do not know the exact cause. Long-term swelling and damage in the bile ducts or liver can lead to cancer over time. The strongest known risk factor is primary sclerosing cholangitis (PSC), a disease that inflames, scars, and narrows the bile ducts. Other risk factors include stones in the bile ducts inside the liver, long-term viral hepatitis, metabolic syndrome, and inflammatory bowel disease. Some printing workers who were exposed to certain chemicals have also developed CCA.
Doctors use several tests together, because no single test can confirm it. Blood tests show how well your liver and bile flow are working. They can raise concern, but they cannot confirm cancer. A blood marker called CA 19-9 can help, but it can be high in people who do not have cancer. Scans show the bile ducts and the tumor. MRI with MRCP is the most helpful for this. If the tumor looks removable, a PET/CT scan can check for spread. To be sure, doctors take a small tissue sample. They may get it through a bile duct procedure called ERCP or through a biopsy. If the tumor is clearly removable, the biopsy may be skipped, because surgery provides the tissue.
Sometimes. Surgery to remove the whole tumor is the only cure. It works best when the cancer is found early. The part of the liver left behind must be big enough to work safely. After surgery, doctors recommend 6 months of a pill called capecitabine. Some people with PSC and early cancer may be able to have a liver transplant. If the tumor cannot be removed, treatment aims to control it. The usual first choice for people who are well enough is two medicines, gemcitabine and cisplatin, often with a third medicine called durvalumab where it is available.
People with primary sclerosing cholangitis (PSC) should be monitored, even if they feel well. They are at higher risk. Experts suggest a yearly scan, and MRI with MRCP is the suggested choice because it is the best at finding CCA. If you have PSC, tell your doctor promptly about weight loss you cannot explain, belly pain, or yellow skin or eyes. Also tell them if blood tests show worse bile flow or if a scan shows a bile duct that is narrowing. If you have another long-term bile duct or liver condition, ask your provider whether monitoring is right for you.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
